Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Western Smokehouse Partners, a Portfolio Company of AUA Private Equity, Acquires Golden Valley Natural
-
Bitdeer Technologies (BTDR) Announces $150M Share and Warrant Offering
-
Bitdeer Announces Up to $150 Million Private Placement Financing
-
Zscaler (ZS) PT Lowered to $200 at Cantor Fitzgerald
-
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
-
Cantor Fitzgerald Starts Rubrik Inc (RBRK) at Overweight
-
Cantor Fitzgerald Reiterates Overweight Rating on Roivant Sciences (ROIV)
-
Form NPORT-P CANTOR FITZGERALD INFRAS For: Mar 31
-
Cantor Fitzgerald Starts ADC Therapeutics (ADCT) at Overweight
-
Cantor Fitzgerald Starts Codexis, Inc. (CDXS) at Overweight
-
Point and Atalaya Capital Management Close Oversubscribed $141 Million Home Equity Investment Rated Securitization
-
Maxim Group Continues Growth in its Institutional Sales and Trading Division with Hiring of John Novak
-
Gold Reserve Provides Update on Previously Announced Best Efforts Private Placement
-
Origin Investments Launches Origin Exchange
-
McEwen Mining Announces Flow-Through Financing at $14.36 (Cdn$19.59) per Share a 19% Premium to Market
-
Zefiro Methane CCO Tina Reine Featured as a Panelist at the Argus Europe Carbon Conference
-
Gold Reserve Announces up to US$65 Million in Financing Transactions in Connection With a Potential Bid in Relation to the Sale of the Shares of PDV Holdings, Inc., Under the Delaware Proceedings
-
Fannie Mae Prices $708 Million Connecticut Avenue Securities (CAS) REMIC Deal
-
Nyxoah (NYXH) Prices 5.37M Share Offering at $9.25/sh
-
Nyxoah Announces Pricing of Offering
-
NVIDIA (NVDA) PT Raised to $1,400 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Skye Bioscience (SKYE) at Overweight
-
Nyxoah Announces Proposed Offering of Ordinary Shares
-
Cantor Fitzgerald Reiterates Overweight Rating on CyberArk Software (CYBR)
-
Cantor Fitzgerald Downgrades Ouster Inc. (OUST) to Neutral
-
InTandem Capital Partners Announces Investment in Adams Clinical
-
Rubicon Technologies Inc (RBT) PT Lowered to $0.60 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Palo Alto Networks (PANW)
-
Cantor Fitzgerald Starts Zealand Pharma A/S (ZEAL:DC) (ZEAL) at Overweight, 'biotech stock to own'
-
GDEV Inc. (GDEV) Initiated Overweight at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Fulcrum Therapeutics (FULC) at Overweight
-
Caledonia Mining Corporation Plc: Utilisation of the block admission in respect of ATM Sales Agreement
-
Form N-23C3A CANTOR FITZGERALD INFRAS For: May 17
-
Despegar.com (DESP) PT Raised to $17 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Abbvie (ABBV) at Overweight
-
Form 424B3 Cantor Fitzgerald Income
-
CAIS Hosts Third Annual Alternative Investment Summit for Independent Advisors
-
Form 13F-NT Cantor Fitzgerald Europe For: Mar 31
-
Form 13F-NT CANTOR FITZGERALD & CO. For: Mar 31
-
Form 13F-NT CANTOR FITZGERALD SECURI For: Mar 31
-
Form 13F-HR CANTOR FITZGERALD, L. For: Mar 31
-
Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit
-
Nyxoah SA (NYXH) PT Lowered to $17 at Cantor Fitzgerald
-
SoundThinking (SSTI) PT Lowered to $20 at Cantor Fitzgerald
-
Form 10-Q Cantor Fitzgerald Income For: Mar 31
-
Exagen (XGN) PT Raised to $7 at Cantor Fitzgerald
-
Sprott Physical Copper Trust Files Preliminary Prospectus for Proposed Initial Public Offering
-
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Aardvark Therapeutics Announces $85 Million Oversubscribed Series C Financing
-
Markforged Holding Corp. (MKFG) PT Lowered to $1.30 at Cantor Fitzgerald

